Gastroenterology Research, ISSN 1918-2805 print, 1918-2813 online, Open Access
Article copyright, the authors; Journal compilation copyright, Gastroenterol Res and Elmer Press Inc
Journal website http://www.gastrores.org

Original Article

Volume 11, Number 4, August 2018, pages 280-289


Profile of Gut Hormones, Pancreatic Hormones and Pro-inflammatory Cytokines in New Zealand Maori

Figures

Figure 1.
Figure 1. Ghrelin levels in Maori versus non-Maori.
Figure 2.
Figure 2. Pancreatic polypeptide levels in Maori versus non-Maori.
Figure 3.
Figure 3. Interleukin-6 levels in Maori versus non-Maori.

Tables

Table 1. Baseline Participant Characteristics
 
TotalMaoriNon-MaoriP
Data presented as median (interquartile range) or count values.
No. of patients938850.372
Age, years53 (42 - 65)52 (47 - 64)53 (42 - 65)0.978
Sex
  Male574530.372
  Female36432
Smoking status0.339
  Smoker69564
  Non-smoker24321
Exercise0.548
  Yes61259
  No32626
Body mass index, kg/m227.5 (24.6 - 30.8)30.6 (26.1 - 38.0)27.4 (24.4 - 30.6)0.117
Diabetes mellitus0.205
  Yes1028
  No83677
Etiology0.465
  Biliary43340
  Alcohol21120
  Other29425
Recurrence0.452
  Yes28325
  No65560
Severity0.562
  Mild73667
  Moderate14212
  Severe/critical606

 

Table 2. Gut Hormones in Maori Versus Non-Maori
 
Gut hormonesModelRegression coefficient (β)OR95% CIP
LowerUpper
OR: odds ratio; CI: confidence interval. OR indicate membership to Maori. Model 1 for all gut hormones was adjusted for age and sex. Model 2 for all gut hormones was adjusted for age, sex, smoking, exercise, BMI and diabetes mellitus. Model 3 for all gut hormones was adjusted for etiology, recurrence, time since pancreatitis and severity. Model 4 for all gut hormones was adjusted for age, sex, smoking, exercise, BMI, diabetes mellitus, etiology, recurrence, time since pancreatitis and severity.
CholecystokininUnadjusted0.8462.3310.44812.1260.314
10.8362.3080.44611.9430.319
20.6431.9030.35110.3330.456
30.6061.8330.30710.9340.506
40.3621.4370.18611.0810.728
GhrelinUnadjusted0.0751.0781.0221.1360.005
10.0751.0781.0211.1380.007
20.0881.0921.0231.1660.008
30.0791.0821.0121.1570.021
40.1051.1111.0121.2190.027
Gastric inhibitory polypeptideUnadjusted0.0051.0050.9951.0140.354
10.0051.0050.9951.0150.299
20.0051.0050.9941.0170.371
30.0041.0040.9931.0140.505
40.0091.0090.9951.0230.229
GlicentinUnadjusted0.0771.0801.0171.1480.013
10.0811.0841.0181.1550.012
20.0991.1041.0111.2060.027
30.0761.0791.0091.1530.027
40.0831.0860.9831.2000.103
Glucagon-like peptide-1Unadjusted0.2111.2350.9371.6290.135
10.2231.2500.9221.6940.151
20.2211.2470.8941.7400.193
30.2831.3270.9561.8430.091
40.4151.5150.9622.3870.073
Glucagon-like peptide-2Unadjusted0.0861.0900.9691.2260.152
10.0811.0840.9641.2200.178
20.0831.0860.9461.2470.241
30.0891.0930.9571.2480.191
40.0991.1040.9011.3530.341
OxyntomodulinUnadjusted-0.0150.9860.9131.0440.618
1-0.0150.9850.9301.0430.606
2-0.0220.9780.9211.0380.466
3-0.0330.9670.9111.0270.279
4-0.0420.9590.8951.0280.238
Peptide YYUnadjusted0.0031.0030.9971.0090.292
10.0041.0040.9981.0100.226
20.0041.0040.9981.0110.217
30.0051.0050.9981.0110.137
40.0061.0060.9991.0130.111
SecretinUnadjusted2.84117.1320.2431208.8350.191
12.87117.6630.2521238.3000.185
23.51133.4800.2754071.2670.152
31.2863.6180.031427.9320.597
43.23325.3430.06410080.3290.290

 

Table 3. Pancreatic Hormones in Maori Versus Non-Maori
 
Pancreatic hormoneModelRegression coefficient (β)OR95% CIP
LowerUpper
OR: odds ratio; CI: confidence interval. OR indicate for membership to Maori. Model 1 for all pancreatic hormones was adjusted for age and sex. Model 2 for all pancreatic hormones was adjusted for age, sex, smoking, exercise, BMI and diabetes mellitus. Model 3 for all pancreatic hormones was adjusted for etiology, recurrence, time since pancreatitis and severity. Model 4 for all pancreatic hormones was adjusted for age, sex, smoking, exercise, BMI, diabetes mellitus, etiology, recurrence, time since pancreatitis and severity. C-peptide values were log10 transformed.
AmylinUnadjusted-0.3780.6850.3751.2520.219
1-0.3880.6780.3631.2670.223
2-0.9340.3930.1570.9850.046
3-0.4320.6490.3191.3230.234
4-1.4510.2340.0590.9370.040
C-peptideUnadjusted-0.4760.6210.0834.6560.643
1-0.5950.5510.0634.7990.590
2-0.5930.5530.0545.6320.617
3-0.7820.4570.0434.8600.516
4-3.2090.0400.0012.3270.121
GlucagonUnadjusted-0.0010.9990.9831.0160.900
1-0.0010.9990.9821.0170.926
2-0.0010.9990.9801.0190.929
3-0.0030.9970.9781.0160.731
4-0.0020.9980.9761.0210.869
InsulinUnadjusted0.0061.0060.9961.0170.248
10.0061.0060.9961.0160.231
20.0041.0040.9891.0200.619
30.0101.0110.9931.0290.246
40.0061.0060.9851.0270.593
Pancreatic polypeptideUnadjusted0.0111.0111.0031.0180.004
10.0111.0111.0041.0180.003
20.0111.0111.0031.0190.007
30.0111.0111.0031.0190.008
40.0131.0131.0021.0250.024
SomatostatinUnadjusted1.3944.0310.44336.6480.216
11.3864.0010.43836.5580.219
21.7505.7530.53561.8340.149
32.1898.9260.555143.5070.122
43.26826.2530.6831009.5370.079

 

Table 4. Pro-Inflammatory Cytokines in Maori Versus Non-Maori
 
CytokiesModelRegression coefficient (β)OR95% CIP
LowerUpper
OR: odds ratio; CI: confidence interval. OR indicate membership to Maori. Model 1 for all cytokines was adjusted for age and sex. Model 2 for all cytokines was adjusted for age, sex, smoking, exercise, BMI and diabetes mellitus. Model 3 for all cytokines was adjusted for etiology, recurrence, time since pancreatitis and severity. Model 4 for all cytokines was adjusted for age, sex, smoking, exercise, BMI, diabetes mellitus, etiology, recurrence, time since pancreatitis and severity.
Interleukin-6Unadjusted0.1101.1171.0121.2330.029
10.1991.2201.0481.4220.011
20.1971.2181.0311.4380.020
30.2081.2311.0461.4480.012
40.2281.2561.0161.5540.035
Monocyte chemoattractant protein-1Unadjusted0.0051.0050.9971.0140.227
10.0071.0070.9981.0170.134
20.0081.0080.9981.0190.117
30.0051.0050.9971.0140.223
40.0121.0120.9991.0260.070
Tumour necrosis factor-αUnadjusted0.0841.0880.9451.2530.242
10.0961.1010.9541.2710.189
20.0841.0880.9291.2730.294
30.1001.1050.9361.3040.239
40.1861.2040.9631.5060.103